← Eichor
Study identifier: NCT06808464 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

New Approach in the Study of the Autonomic Nervous System Through Cardiac Variability in Sleep Apnea Syndrome.

Condition: Sleep Apnea  ·  Sponsor: University Hospital, Lille

PhaseN/A
Planned participants97
Who can joinAll sexes, 18 Years to 64 Years
Healthy volunteersYes

About this study

The main objective of this study is to compare the different variations of the cardiac variability index measured thanks to the technique developed by the CIC-IT between subjects with severe SAS and healthy subjects with sleep pathology. In a first step, these two groups will be compared in REM sleep phase because it is the period during which the risk of sleep apnea syndrome is the highest. In a second step, the same methodology will be applied for the other sleep phases and correlations will be established with the other markers of cardiac variability (HRV) already known. This will allow to validate a reliable method of screening for SAS that is more accessible in ambulatory settings by means of a machine learning system based on artificial intelligence

This description comes directly from the study's public registry record.

Talk to the study team

Philippe DERAMBURE, PR  ·  0320445962  ·  Philippe.DERAMBURE@chu-lille.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Service de Neurophysiologie - unité de médecine du Sommeil - CHU LilleLille, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06808464